Sandy Draper
Stock Analyst at Guggenheim
(3.61)
# 690
Out of 4,789 analysts
125
Total ratings
56.44%
Success rate
18.1%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $304.69 | +41.78% | 12 | Jul 24, 2024 | |
| ACCD Accolade | Maintains: Buy | $13 → $6 | $6.98 | -14.04% | 5 | Jun 28, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $176.30 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $150.52 | - | 15 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $9.47 | +259.03% | 9 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $4.41 | +126.76% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $58.03 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $1.14 | +75.44% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $174.99 | +50.29% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $4.33 | +592.84% | 3 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $94 | $88.37 | +6.37% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $7.96 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $22.45 | +127.17% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $141.41 | -8.78% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $29.65 | +85.50% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $43.29 | +288.08% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $29.55 | -59.39% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $0.09 | +191,593.29% | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $19.28 | +97.10% | 7 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $3.51 | +1,324.50% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $9.49 | +584.93% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $4.53 | +694.70% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $231.63 | -27.90% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.40 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $14.40 | +337.65% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $304.69
Upside: +41.78%
Accolade
Jun 28, 2024
Maintains: Buy
Price Target: $13 → $6
Current: $6.98
Upside: -14.04%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $176.30
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $150.52
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $9.47
Upside: +259.03%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $4.41
Upside: +126.76%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $58.03
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $1.14
Upside: +75.44%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $174.99
Upside: +50.29%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $4.33
Upside: +592.84%
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $88.37
Upside: +6.37%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $7.96
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $22.45
Upside: +127.17%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $141.41
Upside: -8.78%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $29.65
Upside: +85.50%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $43.29
Upside: +288.08%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $29.55
Upside: -59.39%
Mar 29, 2021
Initiates: Buy
Price Target: $180
Current: $0.09
Upside: +191,593.29%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $19.28
Upside: +97.10%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $3.51
Upside: +1,324.50%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $9.49
Upside: +584.93%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $4.53
Upside: +694.70%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $231.63
Upside: -27.90%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.40
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $14.40
Upside: +337.65%